Study of CM-24 (MK-6018) Alone and In Combination With Pembrolizumab (MK-3475) in Participants With Selected Advanced or Recurrent Malignancies (MK-6018-001)

Clinical trial NCT02346955 · TERMINATED

Trial details

NCT number: NCT02346955
Sponsor: Famewave Ltd.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Carcinoma (NSCLC)Melanoma Bladder Cancer Colorectal Cancer Gastric Cancer Ovarian Cancer

Start date: 2015-02-01
Primary completion: 2017-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.